Abstract
Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 1783-1791 |
Number of pages | 9 |
Journal | Cancer Epidemiology Biomarkers & Prevention |
Volume | 21 |
Issue number | 10 |
DOIs | |
Publication status | Published - 2012 |
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium. / Warren, H; Dudbridge, F; Fletcher, O et al.
In: Cancer Epidemiology Biomarkers & Prevention, Vol. 21, No. 10, 2012, p. 1783-1791.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
AU - Warren, H
AU - Dudbridge, F
AU - Fletcher, O
AU - Orr, N
AU - Johnson, N
AU - Hopper, JL
AU - Apicella, C
AU - Southey, MC
AU - Mahmoodi, M
AU - Schmidt, Marjanka K
AU - Broeks, A
AU - Cornelissen, S
AU - Braaf, LM
AU - Muir, KR
AU - Lophatananon, A
AU - Chaiwerawattana, A
AU - Wiangnon, S
AU - Fasching, PA
AU - Beckmann, MW
AU - Ekici, AB
AU - Schulz-Wendtland, R
AU - Sawyer, EJ
AU - Tomlinson, I
AU - Kerin, M
AU - Burwinkel, B
AU - Marme, F
AU - Schneeweiss, A
AU - Sohn, C
AU - Guenel, P
AU - Laurent-Puig, P
AU - Mulot, C
AU - Bojesen, SE
AU - Nielsen, SF
AU - Flyger, H
AU - Nordestgaard, BG
AU - Milne, RL
AU - Benitez, J
AU - Arias-Perez, JI
AU - Zamora, MP
AU - Anton-Culver, H
AU - Ziogas, A
AU - Bernstein, L
AU - Dur, CC
AU - Brenner, H
AU - Muller, H
AU - Arndt, V
AU - Langheinz, A
AU - Meindl, A
AU - Golatta, M
AU - Bartram, CR
AU - Schmutzler, RK
AU - Brauch, H
AU - Justenhoven, C
AU - Bruning, T
AU - Chang-Claude, J
AU - Wang-Gohrke, S
AU - Eilber, U
AU - Dork, T
AU - Schurmann, P
AU - Bremer, M
AU - Hillemanns, P
AU - Nevanlinna, H
AU - Muranen, TA
AU - Aittomaki, K
AU - Blomqvist, C
AU - Bogdanova, N
AU - Antonenkova, N
AU - Rogov, Y
AU - Bermisheva, M
AU - Prokofyeva, D
AU - Zinnatullina, G
AU - Khusnutdinova, E
AU - Lindblom, A
AU - Margolin, S
AU - Mannermaa, A
AU - Kosma, VM
AU - Hartikainen, JM
AU - Kataja, V
AU - Chenevix-Trench, G
AU - Beesley, J
AU - Chen, XQ
AU - Lambrechts, D
AU - Smeets, A
AU - Paridaens, R
AU - Weltens, C
AU - Flesch-Janys, D
AU - Buck, K
AU - Behrens, S
AU - Peterlongo, P
AU - Bernard, L
AU - Manoukian, S
AU - Radice, P
AU - Couch, FJ
AU - Vachon, C
AU - Wang, XS
AU - Olson, J
AU - Giles, G
AU - Baglietto, L
AU - McLean, CA
AU - Severi, G
AU - John, EM
AU - Miron, A
AU - Winqvist, R
AU - Pylkas, K
AU - Jukkola-Vuorinen, A
AU - Grip, M
AU - Andrulis, IL
AU - Knight, JA
AU - Mulligan, AM
AU - Weerasooriya, N
AU - Devilee, P
AU - Tollenaar, RAEM
AU - Martens, John
AU - Seynaeve, Caroline
AU - Hooning, Maartje
AU - Hollestelle, Antoinette
AU - Jager, Agnes
AU - Tilanus - Linthorst, Madeleine
AU - Hall, P
AU - Czene, K
AU - Liu, JJ
AU - Li, JM
AU - Cox, A
AU - Cross, SS
AU - Brock, IW
AU - Reed, MWR
AU - Pharoah, P
AU - Blows, FM
AU - Dunning, AM
AU - Ghous-saini, M
AU - Ashworth, A
AU - Swerdlow, A
AU - Jones, M
AU - Schoemaker, M
AU - Easton, DF
AU - Humphreys, M
AU - Wang, Q (Qing)
AU - Peto, J
AU - dos-Santos-Silva, I
AU - Truong, T
PY - 2012
Y1 - 2012
N2 - Background: Our recent genome-wide association study identified a novel breast cancer susceptibility locus at 9q31.2 (rs865686). Methods: To further investigate the rs865686-breast cancer association, we conducted a replication study within the Breast Cancer Association Consortium, which comprises 37 case-control studies (48,394 cases, 50,836 controls). Results: This replication study provides additional strong evidence of an inverse association between rs865686 and breast cancer risk [study-adjusted per G-allele OR, 0.90; 95% confidence interval (CI), 0.88; 0.91, P = 2.01 x 10(-29)] among women of European ancestry. There were ethnic differences in the estimated minor (G)-allele frequency among controls [0.09, 0.30, and 0.38 among, respectively, Asians, Eastern Europeans, and other Europeans; P for heterogeneity (P-het) -1.3 x 10(-143)], but n Conclusions: This study is the first to show that rs865686 is a susceptibility marker for ER+ breast cancer. Impact: The findings further support the view that genetic susceptibility varies according to tumor subtype. Cancer Epidemiol Biomarkers Prev; 21(10); 1783-91. (c) 2012 AACR.
AB - Background: Our recent genome-wide association study identified a novel breast cancer susceptibility locus at 9q31.2 (rs865686). Methods: To further investigate the rs865686-breast cancer association, we conducted a replication study within the Breast Cancer Association Consortium, which comprises 37 case-control studies (48,394 cases, 50,836 controls). Results: This replication study provides additional strong evidence of an inverse association between rs865686 and breast cancer risk [study-adjusted per G-allele OR, 0.90; 95% confidence interval (CI), 0.88; 0.91, P = 2.01 x 10(-29)] among women of European ancestry. There were ethnic differences in the estimated minor (G)-allele frequency among controls [0.09, 0.30, and 0.38 among, respectively, Asians, Eastern Europeans, and other Europeans; P for heterogeneity (P-het) -1.3 x 10(-143)], but n Conclusions: This study is the first to show that rs865686 is a susceptibility marker for ER+ breast cancer. Impact: The findings further support the view that genetic susceptibility varies according to tumor subtype. Cancer Epidemiol Biomarkers Prev; 21(10); 1783-91. (c) 2012 AACR.
U2 - 10.1158/1055-9965.EPI-12-0526
DO - 10.1158/1055-9965.EPI-12-0526
M3 - Article
VL - 21
SP - 1783
EP - 1791
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
SN - 1055-9965
IS - 10
ER -